Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-740-4 | CAS number: 110-15-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- unknown
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study published in a peer-reviewed journal, Read across.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- less animals, shorter observation period, no body weights reported
- Principles of method if other than guideline:
- Administration of 5 different to doses to groups of 4 male and 4 female rats each.
Observation period 10 days.
Recording of clinical signs and mortality.
Necropsy of survivors. - GLP compliance:
- not specified
- Test type:
- other: standard procedure with variations
- Limit test:
- no
Test material
- Reference substance name:
- Sodium hydrogen succinate
- EC Number:
- 220-871-2
- EC Name:
- Sodium hydrogen succinate
- Cas Number:
- 2922-54-5
- IUPAC Name:
- sodium hydrogen succinate
- Reference substance name:
- Monosodium succinate
- IUPAC Name:
- Monosodium succinate
- Details on test material:
- - Name of test material (as cited in study report): Monosodium succinate
- Analytical purity: 100.2 % (99.7-100.7 %)
- Producer: Mitsubishi Kasei Food Co. (Tokyo, Japan)
- Provider: Japan Food Additives Association (Tokyo, Japan)
- Stability under test conditions: The stability of a 2 % aqueous solution of the test substance was ascertained for at least one week at room temperature.
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Japan, Inc. (Kanagawa, Japan)
- Status: SPF
- Age at study initiation: 6 weeks
- Weight at study initiation: between 100 and 200 g, not reported (only growth curves available)
- Fasting period before study: none reported
- Diet: basal diet (CRF-1), Oriental Yeast Inc., Tokyo, Japan)
- Water: tap water
- Acclimation period: one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): not reported
- Humidity (%): not reported
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): not reported
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- distilled water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: not reported
- Amount of vehicle (if gavage): not reported
- Justification for choice of vehicle: not reported
MAXIMUM DOSE VOLUME APPLIED: not reported - Doses:
- 0.5, 1, 2, 4, 8 g monosodium succinate per kg body weight
- No. of animals per sex per dose:
- 4
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 10 days
- Frequency of observations and weighing: not reported
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, necropsy - Statistics:
- None reported
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 8 000 other: mg Na-succinate / kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 6 740 other: mg succinic acid / kg bw
- Based on:
- other: LD50 for Na-succinate was transformed to succinic acid, taking into account the different molecular weights.
- Remarks on result:
- other: The transformation from Na-succinate to succinic acid seems justified, as both substances will be in the ionised form in dilute aqueous solution.
- Mortality:
- 1/4 females (dose: 8 g/kg) at week 1
- Clinical signs:
- other: 4 or 8 g/kg: decrease in spontaneous activity, recovering in a few days
- Gross pathology:
- 8 g/kg: haemorrhage of the lungs in some animals
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- Migrated information
- Conclusions:
- The LD50 in an acute toxicity study with rats was >8000 mg monosodium succinate per kg body weight.
No classification for monosodium succinate is derived from the results of this study and also no classification for succinic acid.
The corresponding LC50 of succinic acid is >6740 mg/kg bw. The transformation of the LD50 from monosodium succinate to succinic acid seems justified, as both substances will be in the ionised form in dilute aqueous solution and the relevant anion is then the same. - Executive summary:
Monosodium succinate was dissolved in distilled water and was administered orally via gavage to 5 groups of 4 male and 4 female rats each at doses of 0.5, 1, 2, 4 or 8 g per kg body weight. The survivors were necropsied after 10 days.
No other clinical signs were noted than a transient decrease in spontaneous activity of the animals at the highest dose. One high dosed female died in week 1. Necropsy showed haemorrhage of the lungs in some high dose group animals.
The LD50 was higher than 8000 mg monosodium succinate per mg body weight. Even if the different molecular weights of monosodium succinate and succinic acid are taken into account, the LD50 is far above 2000 mg per kg body weight and no classification is derived for succinic acid.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.